Today, the COB, Pres & CEO of Idexx Laboratories (IDXX), Jonathan Ayers, sold shares of IDXX for $6.97M.
Following Jonathan Ayers’ last IDXX Sell transaction on February 22, 2019, the stock climbed by 41.3%. This is Ayers’ first Sell trade following 13 Buy transactions.
See today’s analyst top recommended stocks >>
Based on Idexx Laboratories’ latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $576 million and quarterly net profit of $103 million. In comparison, last year the company earned revenue of $538 million and had a net profit of $89.45 million. IDXX’s market cap is $21.61B and the company has a P/E ratio of 56.54. Currently, Idexx Laboratories has an average volume of 493.5K.
The insider sentiment on Idexx Laboratories has been neutral according to 64 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy and water testing markets. It operates through the following segments: Companion Animal Group; Water; Livestock, Poultry, and Dairy; and Other.
